RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR, Accountable Care organizations, health care transparency issues, e-prescribing and evolving the nation's health IT system. Regulations and policies that focus on improving Medicare Part C and D. Policies related to stopping prescription medication diversion and abuse. Issues related to the creation of a Biosimilar marketplace in the United States. Issues related to mail order coverage. Issues related to Part D coverage for Medicare beneficiaries in hospice care
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Medicare/Medicaid MMM
Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs, and related entities. Monitoring potential health-related offsets related to Medicare Part D and the Medicaid drug benefit. Exchange-based pharmacy benefit structure and coverage issues. Issues related to regulations and guidance that impact mail order and specialty pharmacies for Medicare purposes. Polices related to prescription drug diversion and abuse. Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care. Issues related to coding and reimbursement of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Pharmacy PHA
H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy. Rules, regulations and guidance specific to prescription drug pricing, generic utilization, biosimilars and specialty pharmacy. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in naming policies for upcoming biosimilars. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefit. Issues regarding prescription drug coverage for public benefit programs. Issues related to Part D coverage for Medicare beneficiaries in hospice care.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.